The Effects of Aerobic Exercise Training on Cardiorespiratory Fitness in Stroke Patients

The Effects of Aerobic Exercise Training on Cardiorespiratory Fitness, Functional Capacity, Balance and Ventricular Repolarization Indices in Stroke Patients

Background:

Aerobic exercise training has favorable effects on quality of life, motor recovery, and aerobic endurance after stroke.

Objectives: In this study, the investigators aimed to explore the effects of anti-gravity treadmill gait training and underwater walking therapy on cardiorespiratory fitness in stroke survivors.

Study Overview

Detailed Description

Methods: Seventy patients with a history of stroke were admitted to our center between July 2017 and January 2018. Subjects who participated in the study were randomly assigned to anti-gravity treadmill training, underwater walking therapy, and control group. Investigators examined the aerobic capacity of participants by using the 6-minute walk test and cycle ergometer testing before starting the treatment along with a one-month follow-up. The patient's balance was examined by using the Berg Balance Scale (BBS).

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Gaziler Physical Theraphy and Rehabilitation
    • Konya
      • Meram, Konya, Turkey
        • Konya City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients between the ages of 18 and 80 and diagnosed with stroke and time from stroke onset to admission were longer than three months
  • Independent walking ability more than 10 meters with or without assistance
  • Patients whose cognitive and functional status were suitable for the training program

Exclusion Criteria:

  • Had a previous history of stroke
  • Bilateral hemiplegia
  • Leg-length difference >2.0 cm
  • Fixed flexion contracture or severe joint deformity
  • Bladder or bowel incontinence
  • Open wound
  • Cardiovascular complaints and can not tolerate exercise training
  • Other neurological comorbidities including, multiple sclerosis (MS), spinal cord injury (SCI), traumatic brain injury (TBI), Parkinson's disease, and intracranial tumors
  • Congestive heart failure
  • Atrial fibrillation (AF), use of antiarrhythmic drugs affecting QT duration, any type of bundle branch block on electrocardiogram (ECG)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional theraphy group
13 patients received twenty sessions of conventional therapy for four weeks
Seventy patients with history of stroke admitted to our center between July 2017 and January 2018. Subjects participated in the study were randomly assigned to anti-gravity treadmill training, underwater walking therapy and control group. We examined aerobic capacity of participants by using 6-minute walk test and cycle ergometer testing before starting the treatment along with one month follow up. Patient's balance examined by using the Berg Balance Scale (BBS).
Active Comparator: Anti gravity treadmill training
13 patients received twenty sessions of conventional therapy for four weeks and Alter-G training was performed 3 days/week for 4 weeks, with up to 30 min. of training per session.
Seventy patients with history of stroke admitted to our center between July 2017 and January 2018. Subjects participated in the study were randomly assigned to anti-gravity treadmill training, underwater walking therapy and control group. We examined aerobic capacity of participants by using 6-minute walk test and cycle ergometer testing before starting the treatment along with one month follow up. Patient's balance examined by using the Berg Balance Scale (BBS).
Active Comparator: Underwater walking therapy group
13 patients received twenty sessions of conventional therapy for four weeks and three sessions of aerobic exercise treatment of 45 minutes per week underwater
Seventy patients with history of stroke admitted to our center between July 2017 and January 2018. Subjects participated in the study were randomly assigned to anti-gravity treadmill training, underwater walking therapy and control group. We examined aerobic capacity of participants by using 6-minute walk test and cycle ergometer testing before starting the treatment along with one month follow up. Patient's balance examined by using the Berg Balance Scale (BBS).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-minute walk test
Time Frame: Change from baseline resting heart rate at 4 weeks
Resting heart rate
Change from baseline resting heart rate at 4 weeks
6-minute walk test
Time Frame: Change from baseline maximum heart rate at 4 weeks
Maximum heart rate
Change from baseline maximum heart rate at 4 weeks
6-minute walk test
Time Frame: Change from baseline length of walking distance at 4 weeks
Length of walking distance
Change from baseline length of walking distance at 4 weeks
Cycle ergometer training
Time Frame: Change from baseline maximum heart rate at 4 weeks
Maximum heart rate
Change from baseline maximum heart rate at 4 weeks
Cycle ergometer training
Time Frame: Change from baseline period of completion of test at 4 weeks
Period of completion of test
Change from baseline period of completion of test at 4 weeks
Cycle ergometer training
Time Frame: Change from baseline METs scores at 4 weeks
METs scores
Change from baseline METs scores at 4 weeks
Cycle ergometer training
Time Frame: Change from baseline VO2 max at 4 weeks
VO2 max
Change from baseline VO2 max at 4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Echocardiographic parameters
Time Frame: Change from baseline LV ejection fraction at 4 weeks
LV ejection fraction
Change from baseline LV ejection fraction at 4 weeks
Electrocardiographic parameters
Time Frame: Change from baseline QTc at 4 weeks
QTc
Change from baseline QTc at 4 weeks
Electrocardiographic parameters
Time Frame: Change from baseline Tp-e interval at 4 weeks
Tp-e interval
Change from baseline Tp-e interval at 4 weeks
Electrocardiographic parameters
Time Frame: Change from baseline Tp-e/ QT at 4 weeks
Tp-e/ QT
Change from baseline Tp-e/ QT at 4 weeks
Electrocardiographic parameters
Time Frame: Change from baseline Tp-e/QTc at 4 weeks
Tp-e/QTc
Change from baseline Tp-e/QTc at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

January 31, 2018

Study Completion (Actual)

January 31, 2018

Study Registration Dates

First Submitted

August 25, 2021

First Submitted That Met QC Criteria

September 16, 2021

First Posted (Actual)

September 27, 2021

Study Record Updates

Last Update Posted (Actual)

September 27, 2021

Last Update Submitted That Met QC Criteria

September 16, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke, Cardiovascular

Clinical Trials on The Effects of Aerobic Exercise Training on Cardiorespiratory Fitness, Functional Capacity, Balance and Ventricular Repolarization Indices in Stroke Patients

Subscribe